Clinical Trial Update: A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Age(SGA) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating recombinant human growth hormone injections for short children with small-for-gestational-age; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Stature
• Small For Gestational Age

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Small for Gestational Age Infant | Phase 3 | Status: UNKNOWN